471 related articles for article (PubMed ID: 19839966)
1. Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence.
Longo M; Wickes W; Smout M; Harrison S; Cahill S; White JM
Addiction; 2010 Jan; 105(1):146-54. PubMed ID: 19839966
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence.
Shearer J; Darke S; Rodgers C; Slade T; van Beek I; Lewis J; Brady D; McKetin R; Mattick RP; Wodak A
Addiction; 2009 Feb; 104(2):224-33. PubMed ID: 19149817
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
4. A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal.
Cruickshank CC; Montebello ME; Dyer KR; Quigley A; Blaszczyk J; Tomkins S; Shand D
Drug Alcohol Rev; 2008 May; 27(3):326-33. PubMed ID: 18368615
[TBL] [Abstract][Full Text] [Related]
5. Socio-demographic factors associated with methamphetamine treatment contact among dependent methamphetamine users in Sydney, Australia.
McKetin R; Kelly E
Drug Alcohol Rev; 2007 Mar; 26(2):161-8. PubMed ID: 17364851
[TBL] [Abstract][Full Text] [Related]
6. Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.
Miles SW; Sheridan J; Russell B; Kydd R; Wheeler A; Walters C; Gamble G; Hardley P; Jensen M; Kuoppasalmi K; Tuomola P; Föhr J; Kuikanmäki O; Vorma H; Salokangas R; Mikkonen A; Kallio M; Kauhanen J; Kiviniemi V; Tiihonen J
Addiction; 2013 Jul; 108(7):1279-86. PubMed ID: 23297867
[TBL] [Abstract][Full Text] [Related]
7. The effects of modafinil treatment on neuropsychological and attentional bias performance during 7-day inpatient withdrawal from methamphetamine dependence.
Hester R; Lee N; Pennay A; Nielsen S; Ferris J
Exp Clin Psychopharmacol; 2010 Dec; 18(6):489-97. PubMed ID: 21186923
[TBL] [Abstract][Full Text] [Related]
8. Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men.
Shoptaw S; Reback CJ; Peck JA; Yang X; Rotheram-Fuller E; Larkins S; Veniegas RC; Freese TE; Hucks-Ortiz C
Drug Alcohol Depend; 2005 May; 78(2):125-34. PubMed ID: 15845315
[TBL] [Abstract][Full Text] [Related]
9. Clinical effects beyond cocaine use of sustained-release dexamphetamine for the treatment of cocaine dependent patients with comorbid opioid dependence: secondary analysis of a double-blind, placebo-controlled randomized trial.
Blanken P; Nuijten M; van den Brink W; Hendriks VM
Addiction; 2020 May; 115(5):917-923. PubMed ID: 31908066
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study.
Spencer TJ; Abikoff HB; Connor DF; Biederman J; Pliszka SR; Boellner S; Read SC; Pratt R
Clin Ther; 2006 Mar; 28(3):402-18. PubMed ID: 16750455
[TBL] [Abstract][Full Text] [Related]
11. A pilot randomised controlled trial of modafinil during acute methamphetamine withdrawal: feasibility, tolerability and clinical outcomes.
Lee N; Pennay A; Hester R; McKetin R; Nielsen S; Ferris J
Drug Alcohol Rev; 2013 Jan; 32(1):88-95. PubMed ID: 22630616
[TBL] [Abstract][Full Text] [Related]
12. A multicenter, randomized, double-blind, placebo-controlled trial of intravenous ibuprofen 400 and 800 mg every 6 hours in the management of postoperative pain.
Southworth S; Peters J; Rock A; Pavliv L
Clin Ther; 2009 Sep; 31(9):1922-35. PubMed ID: 19843482
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms.
Kampman KM; Dackis C; Lynch KG; Pettinati H; Tirado C; Gariti P; Sparkman T; Atzram M; O'Brien CP
Drug Alcohol Depend; 2006 Nov; 85(2):129-37. PubMed ID: 16697124
[TBL] [Abstract][Full Text] [Related]
14. Drug court treatment for methamphetamine dependence: treatment response and posttreatment outcomes.
Marinelli-Casey P; Gonzales R; Hillhouse M; Ang A; Zweben J; Cohen J; Hora PF; Rawson RA;
J Subst Abuse Treat; 2008 Mar; 34(2):242-8. PubMed ID: 17596903
[TBL] [Abstract][Full Text] [Related]
15. Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo.
Levin FR; Evans SM; Brooks DJ; Garawi F
Drug Alcohol Depend; 2007 Feb; 87(1):20-9. PubMed ID: 16930863
[TBL] [Abstract][Full Text] [Related]
16. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence.
Rawson RA; Marinelli-Casey P; Anglin MD; Dickow A; Frazier Y; Gallagher C; Galloway GP; Herrell J; Huber A; McCann MJ; Obert J; Pennell S; Reiber C; Vandersloot D; Zweben J;
Addiction; 2004 Jun; 99(6):708-17. PubMed ID: 15139869
[TBL] [Abstract][Full Text] [Related]
17. Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: a comparison of mirtazapine and modafinil with treatment as usual.
McGregor C; Srisurapanont M; Mitchell A; Wickes W; White JM
J Subst Abuse Treat; 2008 Oct; 35(3):334-42. PubMed ID: 18329221
[TBL] [Abstract][Full Text] [Related]
18. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
19. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
[TBL] [Abstract][Full Text] [Related]
20. Predicting in-treatment performance and post-treatment outcomes in methamphetamine users.
Hillhouse MP; Marinelli-Casey P; Gonzales R; Ang A; Rawson RA;
Addiction; 2007 Apr; 102 Suppl 1():84-95. PubMed ID: 17493057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
